bupropion has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duthaler, U; Grouzmann, E; Hysek, CM; Liechti, ME; Rickli, A; Schaffner, A; Schmid, Y | 1 |
Kraemer, T; Liechti, ME; Rickli, A; Schmid, Y; Schmidhauser, C; Steuer, AE; Tingelhoff, EH | 1 |
2 trial(s) available for bupropion and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.
Topics: Adult; Bupropion; Cross-Over Studies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Drug Interactions; Epinephrine; Female; Heart Rate; Humans; Hydrocortisone; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Oxytocin; Prolactin; Psychotropic Drugs; Young Adult | 2015 |
Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.
Topics: Area Under Curve; Bupropion; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Double-Blind Method; Humans; Inactivation, Metabolic; Metabolic Networks and Pathways; N-Methyl-3,4-methylenedioxyamphetamine; Plasma; Stereoisomerism | 2016 |